Comparison of Renal Safety and Efficacy of Telbivudine, Entecavir and Tenofovir Treatment in Chronic Hepatitis B Patients: Real World Experience

Clinical Microbiology and Infection - United Kingdom
doi 10.1016/j.cmi.2015.05.035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Renal Safety of Tenofovir and/or Entecavir in Patients With Chronic HBV Monoinfection

Therapeutics and Clinical Risk Management
2017English

A Comparison of 48-Week Treatment Efficacy Between Clevudine and Entecavir in Treatment-Naïve Patients With Chronic Hepatitis B

Hepatology International
Hepatology
2011English

Potential Effects of Telbivudine Versus Entecavir on Renal Function in Patients With Chronic Hepatitis B Virus Receiving Glucocorticoids Therapy

Therapeutic Apheresis and Dialysis
HematologyNephrology
2019English

Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection During Pregnancy With Lamivudine, Telbivudine, and Tenofovir: A Meta-Analysis

Journal of Clinical and Translational Hepatology
2019English

Letter: Distinct Hepatitis B Virus Relapse Rates After Discontinuing Tenofovir and Entecavir Therapy in Chronic Hepatitis B Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Renal Concerns in the Treatment of Chronic Hepatitis B With Tenofovir

Journal of Renal and Hepatic Disorders
2017English

Pgi14 Perceived Value Assessment of Entecavir Versus Tenofovir in Chronic Hepatitis B

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Comparison of the Efficacies and Safety of Combined Therapy Between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients With Hepatitis B Virus Infection in Real-World Practice

PLoS ONE
Multidisciplinary
2016English

The Real-World Efficacy and Safety of Direct-Acting Oral Antiviral Treatment in Chronic Hepatitis C Genotype 1 Patients in Turkey

Cumhuriyet Medical Journal
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy